Alpha Cognition Inc. Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax
Alpha Cognition Inc. (ACOG) reported Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax of -$4.19 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes
us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax · last filed 2025-03-31
- Alpha Cognition Inc. translation adjustment functional to reporting currency, increase (decrease), gross of tax for the quarter ending 2023-12-31 was $0.00.
- Alpha Cognition Inc. translation adjustment functional to reporting currency, increase (decrease), gross of tax for the quarter ending 2023-09-30 was -$4.19M.
- Alpha Cognition Inc. translation adjustment functional to reporting currency, increase (decrease), gross of tax for fiscal 2023 was -$4.19M.
| Period end | Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax 3 month | Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax 6 month | Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax 9 month | Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$4.19M derived: sum of 2 quarters · filed 2025-03-31 | -$4.19M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$4.19M 10-Q · filed 2024-11-14 | -$4.19M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |